Search Results - "Li, Suzanne"

Scleroderma in Children and Adolescents: Localized Scleroderma and Systemic Sclerosis by Li, Suzanne C

“…Scleroderma is a rare disease that has two main forms: localized scleroderma (LS) and systemic sclerosis (SSc). Both are chronic diseases, can present in…”
Get full text

Treatment of juvenile localized scleroderma: current recommendations, response factors, and potential alternative treatments by Li, Suzanne C.

“…Purpose of review Juvenile localized scleroderma (jLS) is a chronic autoimmune and fibrosing disease associated with a high risk for functional impairment…”
Get full text

Juvenile Localized Scleroderma: Updates and Differences from Adult-Onset Disease by Vasquez-Canizares, Natalia, Li, Suzanne C

Get full text

Morbidity and Disability in Juvenile Localized Scleroderma: The Case for Early Recognition and Systemic Immunosuppressive Treatment by Li, Suzanne C., O'Neil, Kathleen M., Higgins, Gloria C.

Get full text

Validation of the total morbidity score and investigation of the efficacy of methotrexate in localized scleroderma by Hoppe, Ann-Kathrin, Li, Suzanne C, Foeldvari, Ivan

“…Localized scleroderma is an autoimmune disease belonging to the group of collagenoses, which can manifest cutaneously and extracutaneously. The extracutaneous…”
Get full text

Immunopathogenesis of Pediatric Localized Scleroderma by Torok, Kathryn S, Li, Suzanne C, Jacobe, Heidi M, Taber, Sarah F, Stevens, Anne M, Zulian, Francesco, Lu, Theresa T

“…Localized scleroderma (LS) is a complex disease characterized by a mixture of inflammation and fibrosis of the skin that, especially in the pediatric…”
Get full text

Preliminary Evidence on Abatacept Safety and Efficacy in Refractory Juvenile Localized Scleroderma by Li, Suzanne C, Torok, Kathryn S, Ishaq, Sarah S, Buckley, Mary, Edelheit, Barbara, Ede, Kaleo C, Liu, Christopher, Rabinovich, C Egla

“…To evaluate the safety and efficacy of abatacept treatment for refractory juvenile localized scleroderma (jLS) in a retrospective study. A multicentre cohort…”
Get full text

Consensus Treatment Plans for Chronic Nonbacterial Osteomyelitis Refractory to Nonsteroidal Antiinflammatory Drugs and/or With Active Spinal Lesions by Zhao, Yongdong, Wu, Eveline Y., Oliver, Melissa S., Cooper, Ashley M., Basiaga, Matthew L., Vora, Sheetal S., Lee, Tzielan C., Fox, Emily, Amarilyo, Gil, Stern, Sara M., Dvergsten, Jeffrey A., Haines, Kathleen A., Rouster‐Stevens, Kelly A., Onel, Karen B., Cherian, Julie, Hausmann, Jonathan S., Miettunen, Paivi, Cellucci, Tania, Nuruzzaman, Farzana, Taneja, Angela, Barron, Karyl S., Hollander, Matthew C., Lapidus, Sivia K., Li, Suzanne C., Ozen, Seza, Girschick, Hermann, Laxer, Ronald M., Dedeoglu, Fatma, Hedrich, Christian M., Ferguson, Polly J.

“…Objective To develop standardized treatment regimens for chronic nonbacterial osteomyelitis (CNO), also known as chronic recurrent multifocal osteomyelitis…”
Get full text

Development of consensus treatment plans for juvenile localized scleroderma: A roadmap toward comparative effectiveness studies in juvenile localized scleroderma by Li, Suzanne C., Torok, Kathryn S., Pope, Elena, Dedeoglu, Fatma, Hong, Sandy, Jacobe, Heidi T., Rabinovich, C. Egla, Laxer, Ronald M., Higgins, Gloria C., Ferguson, Polly J., Lasky, Andrew, Baszis, Kevin, Becker, Mara, Campillo, Sarah, Cartwright, Victoria, Cidon, Michael, Inman, Christi J., Jerath, Rita, O'Neil, Kathleen M., Vora, Sheetal, Zeft, Andrew, Wallace, Carol A., Ilowite, Norman T., Fuhlbrigge, Robert C.

“…Objective Juvenile localized scleroderma (LS) is a chronic inflammatory skin disorder associated with substantial morbidity and disability. Although a wide…”
Get full text

The Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans: Toward Comparative Effectiveness in the Pediatric Rheumatic Diseases by Ringold, Sarah, Nigrovic, Peter A, Feldman, Brian M, Tomlinson, George A, von Scheven, Emily, Wallace, Carol A, Huber, Adam M, Schanberg, Laura E, Li, Suzanne C, Weiss, Pamela F, Fuhlbrigge, Robert C, Morgan, Esi M, Kimura, Yukiko

“…The pediatric rheumatic diseases are a heterogeneous group of rare diseases, posing a number of challenges for the use of traditional clinical and…”
Get full text

Extracutaneous involvement is common and associated with prolonged disease activity and greater impact in juvenile localized scleroderma by Li, Suzanne C, Higgins, Gloria C, Chen, Mallory, Torok, Kathryn S, Rabinovich, C Egla, Stewart, Katie, Laxer, Ronald M, Pope, Elena, Haines, Kathleen A, Punaro, Marilynn, O'Neil, Kathleen M

“…The aim of this study was to evaluate factors associated with extracutaneous involvement (ECI) in juvenile localized scleroderma (jLS). A prospective,…”
Get full text

Initial Results from a Pilot Comparative Effectiveness Study of 3 Methotrexate-based Consensus Treatment Plans for Juvenile Localized Scleroderma by Li, Suzanne C, Torok, Kathryn S, Rabinovich, C Egla, Dedeoglu, Fatma, Becker, Mara L, Ferguson, Polly J, Hong, Sandy D, Ibarra, Maria F, Stewart, Katie, Pope, Elena, Higgins, Gloria C, Laxer, Ronald M, Mason, 2nd, Thomas, Fuhlbrigge, Robert C, Andrews, Tracy

“…To perform a comparative effectiveness feasibility study in juvenile localized scleroderma (LS), using standardized treatment regimens (consensus treatment…”
Get full text

Immunopathogenesis of Juvenile Systemic Sclerosis by Stevens, Anne M, Torok, Kathryn S, Li, Suzanne C, Taber, Sarah F, Lu, Theresa T, Zulian, Francesco

“…Juvenile-onset systemic sclerosis (jSSc) is a rare and severe autoimmune disease with associated life-threatening organ inflammation and evidence of fibrosis…”
Get full text

New Features for Measuring Disease Activity in Pediatric Localized Scleroderma by Li, Suzanne C, Li, Xiaohu, Pope, Elena, Stewart, Katie, Higgins, Gloria C, Rabinovich, C Egla, O'Neil, Kathleen M, Haines, Kathleen A, Laxer, Ronald M, Punaro, Marilynn, Jacobe, Heidi, Andrews, Tracy, Wittkowski, Knut, Nyirenda, Themba, Foeldvari, Ivan, Torok, Kathryn S

“…To identify clinical features that define disease activity in pediatric localized scleroderma (LS), and determine their specificity and importance. We…”
Get full text

Capturing the Range of Disease Involvement in Localized Scleroderma: The Localized Scleroderma Total Severity Scale by Li, Suzanne C., Rabinovich, C. Egla, Becker, Mara L., Torok, Kathryn S., Ferguson, Polly J., Dedeoglu, Fatma, Hong, Sandy, Sivaraman, Vidya, Laxer, Ronald M., Stewart, Katie, Ibarra, Maria F., Mason, Thomas, Higgins, Gloria, Pope, Elena, Li, Xiaohu, Lozy, Tara, Fuhlbrigge, Robert C., Anderson, E., Benham, H., Feldman, B., Francis, K., Goh, I., Jaquith, J., SchollaertFitch, K., Smith, C., Weiss, J., Wooton, J.

“…Objective Juvenile localized scleroderma (jLS) is a chronic autoimmune disease commonly associated with poor outcomes, including contractures, hemiatrophy,…”
Get full text

Early Outcomes in Children With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis by Morishita, Kimberly A., Moorthy, Lakshmi N., Lubieniecka, Joanna M., Twilt, Marinka, Yeung, Rae S. M., Toth, Mary B., Shenoi, Susan, Ristic, Goran, Nielsen, Susan M., Luqmani, Raashid A., Li, Suzanne C., Lee, Tzielan, Lawson, Erica F., Kostik, Mikhail M., Klein‐Gitelman, Marisa, Huber, Adam M., Hersh, Aimee O., Foell, Dirk, Elder, Melissa E., Eberhard, Barbara A., Dancey, Paul, Charuvanij, Sirirat, Benseler, Susanne M., Cabral, David A.

“…Objective To characterize the early disease course in childhood‐onset antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV) and the 12‐month…”
Get full text

Altered expression of K13 disrupts DNA replication and repair in Plasmodium falciparum by Gibbons, Justin, Button-Simons, Katrina A, Adapa, Swamy R, Li, Suzanne, Pietsch, Maxwell, Zhang, Min, Liao, Xiangyun, Adams, John H, Ferdig, Michael T, Jiang, Rays H Y

“…Plasmodium falciparum exhibits resistance to the artemisinin component of the frontline antimalarial treatment Artemisinin-based Combination Therapy in South…”
Get full text

Proposed Response Parameters for Twelve‐Month Drug Trial in Juvenile Systemic Sclerosis: Results of the Hamburg International Consensus Meetings by Foeldvari, Ivan, Torok, Kathryn S., Anton, Jordi, Blakley, Michael, Constantin, Tamás, Curran, Megan, Cutolo, Maurizio, Denton, Christopher, Fligelstone, Kim, Ingegnoli, Francesca, Li, Suzanne C., Němcová, Dana, Orteu, Catherine, Pilkington, Clarissa, Smith, Vanessa, Stevens, Anne, Klotsche, Jens, Khanna, Dinesh, Costa‐Reis, Patrícia, Del Galdo, Francesco, Hinrichs, Bernd, Kasapcopur, Ozgur, Pain, Clare, Ruperto, Nicolino, Zheng, Alison, Furst, Daniel E.

“…Objective Juvenile systemic sclerosis (SSc) is an orphan disease, associated with high morbidity and mortality. New treatment strategies are much needed, but…”
Get full text

Overview of Juvenile localized scleroderma and its management by Li, Suzanne C., Zheng, Rong-Jun

“…Background Juvenile localized scleroderma (JLS) is a rare pediatric disease characterized by inflammation and skin thickening. JLS is associated with deep…”
Get full text

What are Juvenile-onset systemic sclerosis providers thoughts, experiences, and reasons for autologous stem cell transplant? Result of a multinational survey by Foeldvari, Ivan, Branton, Samantha, Li, Suzanne C, Rosser, Franziska J, Torok, Kathryn S

“…Objective: Juvenile-onset systemic sclerosis (jSSc) is a rare and life-threatening disease with no formal studies evaluating the indications for, access to, or…”
Get full text